BHVN
Biohaven Ltd.
NYSE · Healthcare · Biotechnology · US
$15.69
−1.07%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+44.5%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Apr 30, 2026 | Bailey Gregory · director | A-Award | 68,693 | $9.61 |
| Apr 30, 2026 | HUGIN ROBERT J · director | A-Award | 68,693 | $9.61 |
| Apr 30, 2026 | Heffernan Michael Thomas · director | A-Award | 68,693 | $9.61 |
| Apr 30, 2026 | GREGORY JULIA P · director | A-Award | 68,693 | $9.61 |
| Apr 30, 2026 | CHILDS JOHN W · director | A-Award | 68,693 | $9.61 |
| Apr 30, 2026 | Antonijevic Irina · director | A-Award | 68,693 | $9.61 |
| Apr 30, 2026 | Mehta Kishan · director | A-Award | 68,693 | $9.61 |
| Mar 9, 2026 | CHILDS JOHN W · director | Purchase | 28,400 | $30 |
| Mar 3, 2026 | Buten Matthew · officer: Chief Financial Officer | A-Award | 175,000 | $12 |
| Mar 3, 2026 | Car Bruce · officer: Chief Scientific Officer | A-Award | 175,000 | $12 |
| Mar 3, 2026 | Gentile Kimberly · officer: SVP, Clinical Operations | A-Award | 175,000 | $12 |
| Mar 3, 2026 | Clark George C. · officer: VP, Chief Accounting Officer | A-Award | 50,000 | $12 |
| Mar 3, 2026 | Coric Vlad · director, officer: Chief Executive Officer | A-Award | 550,000 | $12 |
| Jan 7, 2026 | Gentile Kimberly · officer: SVP, Clinical Operations | M-Exempt | 3,750 | $0.00 |
| Jan 7, 2026 | Buten Matthew · officer: Chief Financial Officer | F-InKind | 2,594 | $9.93 |
| Jan 7, 2026 | Car Bruce · officer: Chief Scientific Officer | M-Exempt | 4,750 | $0.00 |
| Jan 7, 2026 | Coric Vlad · director, officer: Chief Executive Officer | M-Exempt | 14,250 | $0.00 |
| Jan 7, 2026 | Gentile Kimberly · officer: SVP, Clinical Operations | F-InKind | 1,956 | $9.93 |
| Jan 7, 2026 | Car Bruce · officer: Chief Scientific Officer | F-InKind | 2,381 | $9.93 |
| Jan 7, 2026 | Coric Vlad · director, officer: Chief Executive Officer | F-InKind | 7,430 | $9.93 |
| Jan 7, 2026 | Clark George C. · officer: VP, Chief Accounting Officer | F-InKind | 1,117 | $9.93 |
| Jan 7, 2026 | Buten Matthew · officer: Chief Financial Officer | M-Exempt | 4,250 | $0.00 |
| Jan 7, 2026 | Clark George C. · officer: VP, Chief Accounting Officer | M-Exempt | 2,500 | $0.00 |
| Nov 18, 2025 | Clark George C. · officer: VP, Chief Accounting Officer | Purchase | 17,000 | $8.52 |
| Nov 17, 2025 | Coric Vlad · director, officer: Chief Executive Officer | Purchase | 333,333 | $7.50 |
| Nov 17, 2025 | CHILDS JOHN W · director | Purchase | 3,333,333 | $7.50 |
| Nov 17, 2025 | Bailey Gregory · director | Purchase | 400,000 | $7.50 |
| May 7, 2025 | Bailey Gregory · director | A-Award | 31,716 | $23 |
| May 7, 2025 | CHILDS JOHN W · director | A-Award | 31,716 | $23 |
| May 7, 2025 | GREGORY JULIA P · director | A-Award | 31,716 | $23 |
Institutional positioning
13F filings over the trailing two quarters
New 94Increased 227Reduced 156Sold out 31
| Filer | Action | Shares | Filed |
|---|---|---|---|
| JANUS HENDERSON GROUP PLC | Increased | 17,534,612 | May 18, 2026 |
| BlackRock, Inc. | Increased | 13,210,585 | Aug 7, 2026 |
| BLACKROCK, INC. | Increased | 11,222,407 | May 13, 2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | Unchanged | 10,286,937 | Aug 14, 2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | Unchanged | 10,286,937 | May 15, 2026 |
| STIFEL FINANCIAL CORP | Increased | 9,941,165 | Aug 12, 2026 |
| STIFEL FINANCIAL CORP | Increased | 9,940,885 | May 12, 2026 |
| Jupiter Topco LLC | New Position | 8,584,675 | Aug 14, 2026 |
| Woodline Partners LP | Increased | 7,660,280 | Aug 14, 2026 |
| STATE STREET CORP | Increased | 6,947,034 | Aug 7, 2026 |
| STATE STREET CORP | Increased | 6,618,803 | May 15, 2026 |
| INFINITUM ASSET MANAGEMENT, LLC | Unchanged | 6,250,000 | Aug 14, 2026 |
| INFINITUM ASSET MANAGEMENT, LLC | Unchanged | 6,250,000 | May 15, 2026 |
| TCG CROSSOVER MANAGEMENT, LLC | Unchanged | 4,631,317 | May 15, 2026 |
| D. E. Shaw & Co., Inc. | Increased | 4,190,195 | Aug 14, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Apr 30, 2026